Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data

Abstract

In this paper we review recent advances in statistical methods for the evaluation of the heterogeneity of treatment effects (HTE), including subgroup identification and estimation of individualized treatment regimens, from randomized clinical trials and observational studies. We identify several types of approaches using the features introduced in Lipkovich, Dmitrienko and D'Agostino (2017) that distinguish the recommended principled methods from basic methods for HTE evaluation that typically rely on rules of thumb and general guidelines (the methods are often referred to as common practices). We discuss the advantages and disadvantages of various principled methods as well as common measures for evaluating their performance. We use simulated data and a case study based on a historical clinical trial to illustrate several new approaches to HTE evaluation.

References in corpus (8)

• Random survival forests
• Performance guarantees for individualized treatment rules
• Discussion on "Bayesian Regression Tree Models for Causal Inference: Regularization, Confounding, and Heterogeneous Effects" by Hahn, Murray and Carvalho
• A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint
• Efficient Targeted Learning of Heterogeneous Treatment Effects for Multiple Subgroups
• A Permutation Test for Assessing the Presence of Individual Differences in Treatment Effects
• Stabilized Direct Learning for Efficient Estimation of Individualized Treatment Rules
• Monte Carlo Sensitivity Analysis for Unmeasured Confounding in Dynamic Treatment Regimes

Cited by in corpus (2)

• Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
• WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors